Clinical trial

Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1…

NCT00807651 · Shanghai Jiao Tong University School of Medicine, Other · Completed

Key facts

NCT number NCT00807651
Title Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes
Official title Safety and Efficacy Study of Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes-a Phase II Study
Lead sponsor Shanghai Jiao Tong University School of Medicine, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Type 1 Diabetes Mellitus
Intervention type Drug, Procedure
Interventions AHSCT, Insulin therapy
Enrollment 40
Start date Feb 1, 2008
Primary completion Jun 1, 2016
Completion Dec 1, 2016
First posted Dec 12, 2008
Last update posted Nov 18, 2021
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies